Atabak Mokari

Chief Financial Officer, Corcept Therapeutics

Bought, 12 months

$0.0M

Sold, 12 months

$18.7M

Companies

Latest trade

Jul 30, 2026

Companies

Corcept TherapeuticsChief Financial Officer −$18.7M

Trades

CORT Sold 80,000 shares at $114.72 · planned $9.2M Jul 30

CORT Sold 40,000 shares at $87.71 · planned $3.5M Jul 15

CORT Sold 40,000 shares at $81.15 · planned $3.2M Jun 15

CORT Sold 40,000 shares at $70.00 · planned $2.8M Jun 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.